Context Therapeutics Inc.(CNTX)

$0.38—Stale · unknown old

Chart

Context Therapeutics Inc.(CNTX)

NASDAQ • Last print unknown ago

$0.38—Stale · unknown old

Chart Studio

CNTX(CNTX)

CNTX

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Insiders Institl.DCF Peers

Q4 2026 EPS Estimate

$-0.10

Nov 4, 2026

Analyst Sentiment

Wall St. Consensus

Buy

6 analysts·Limited coverage

Score

6 Buy (100%)0 Hold (0%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

6100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$4.50

+1072.8%

Consensus

$5.25

+1268.3%

Bull

$6.00

+1463.7%

12-Month Target Range6 analysts

$4.50$5.25$6.00

Current $0.38Consensus

Current Price

$0.38

Upside to Consensus

$4.87

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev—

EPS—

FY2028

Rev—

EPS—

FY2029

Rev+320.41%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$2M	—	$2M	$10M	$25M
Low	$2M	—	$2M	$10M	$25M
High	$2M	—	$2M	$10M	$25M
EBITDA Avg	$-45M	—	$-59M	$-50M	$-45M
Low	$-52M	—	$-67M	$-50M	$-45M
High	$-39M	—	$-40M	$-50M	$-45M
EBIT Avg	$-45M	—	$-59M	$-50M	$-45M
Low	$-52M	—	$-67M	$-50M	$-45M
High	$-39M	—	$-40M	$-50M	$-45M
Net Income Avg	$-45M	$-41M	$-59M	$-50M	$-45M
Low	$-52M	$-44M	$-67M	$-50M	$-45M
High	$-39M	$-37M	$-40M	$-50M	$-45M
EPS Avg	$-0.46	$-0.43	$-0.55	$-0.52	$-0.48
Low	$-0.54	$-0.46	$-0.70	$-0.52	$-0.48
High	$-0.41	$-0.39	$-0.42	$-0.52	$-0.48
Analysts (Rev / EPS)	8 / 7	— / 6	7 / 6	3 / 3	5 / 2

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	—	—	—	—	—	—	$9M	$9M
Low	—	—	—	—	—	—	$9M	$9M
High	—	—	—	—	—	—	$9M	$9M
EBITDA Avg	—	—	—	—	—	—	$-13M	$-14M
Low	—	—	—	—	—	—	$-13M	$-14M
High	—	—	—	—	—	—	$-13M	$-14M
EBIT Avg	—	—	—	—	—	—	$-13M	$-14M
Low	—	—	—	—	—	—	$-13M	$-14M
High	—	—	—	—	—	—	$-13M	$-14M
Net Income Avg	$-10M	$-11M	$-10M	$-9M	$-10M	$-10M	$-13M	$-14M
Low	$-11M	$-14M	$-10M	$-9M	$-10M	$-10M	$-13M	$-14M
High	$-7M	$-9M	$-10M	$-9M	$-10M	$-10M	$-13M	$-14M
EPS Avg	$-0.11	$-0.11	$-0.10	$-0.10	$-0.10	$-0.11	$-0.14	$-0.15
Low	$-0.12	$-0.15	$-0.10	$-0.10	$-0.10	$-0.11	$-0.14	$-0.15
High	$-0.08	$-0.09	$-0.10	$-0.10	$-0.10	$-0.11	$-0.14	$-0.15
Analysts (Rev / EPS)	— / 6	— / 6	— / 2	— / 2	— / 2	— / 2	1 / 5	1 / 5

Earnings Surprises

Recent Analyst Actions

Aug 8, 2024H.C. Wainwright

Context Therapeutics (CNTX) PT Raised to $6 at H.C. Wainwright

Target:$6.00

+156.4%from $2.34

May 16, 2024Piper Sandler

Piper Sandler Starts Context Therapeutics (CNTX) at Overweight

Target:$4.50

+166.3%from $1.69

May 9, 2024H.C. Wainwright

Context Therapeutics (CNTX) PT Raised to $5 at H.C. Wainwright

Target:$5.00

+176.2%from $1.81

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance